← INTEGRA LIFESCIENCES HOLDINGS CORP
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $992.1m | $1.2b | $1.5b | $1.5b | $1.4b | $1.5b | $1.6b | $1.5b | $1.6b | $1.6b | |
| Cost of Revenue | $349.1m | $435.5m | $571.5m | $564.7m | $520.8m | $597.8m | $587.4m | $656.8m | $728.5m | $803.6m | |
| Gross Profit (derived) | $643.0m | $752.7m | $900.9m | $952.9m | $851.0m | $944.6m | $970.3m | $884.7m | $882.1m | $831.6m | |
| Operating expenses: | |||||||||||
| Operating Income (Loss) | $115.3m | $44.8m | $111.0m | $93.8m | $151.4m | $197.2m | $238.9m | $111.5m | $28.4m | ($493.4m) | |
| Additional Financial Items | |||||||||||
| Amortization of Intangible Assets | $13.9m | $20.4m | $21.2m | $27.0m | $27.8m | $16.9m | $13.9m | $12.4m | $21.3m | $15.0m | |
| Foreign Currency Transaction Gain (Loss), Realized | — | ($2.9m) | $1.7m | ($300k) | ($1.6m) | $100k | ($3.3m) | ($4.4m) | ($2.3m) | ($7.4m) | |
| Goodwill, Impairment Loss | — | $0 | — | — | — | — | — | — | — | $511.4m | |
| Income (Loss) from Continuing Operations before Income Taxes, Domestic | $51.4m | ($32.6m) | ($21.2m) | ($38.4m) | $15.1m | $91.2m | $92.6m | ($31.6m) | ($172.3m) | ($469.2m) | |
| Income (Loss) from Continuing Operations, Per Basic Share | $1 | $1 | — | — | — | — | — | — | — | — | |
| Income (Loss) from Continuing Operations, Per Diluted Share | $1 | $1 | — | — | — | — | — | — | — | — | |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | — | — | — | — | — | $214.7m | $213.9m | $81.1m | ($18.2m) | ($563.5m) | |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent | $74.6m | $64.7m | — | — | — | — | — | — | — | — | |
| Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent | $0 | $0 | — | — | — | — | — | — | — | — | |
| Net Income (Loss) Attributable to Parent | $74.6m | $64.7m | $60.8m | $50.2m | $133.9m | $169.1m | $180.6m | $67.7m | ($6.9m) | ($516.5m) | |
| Earnings Per Share, Basic | $1.00 | $0.84 | $0.73 | $0.59 | $1.58 | $2.00 | $2.18 | $0.85 | ($0.09) | ($6.74) | |
| Earnings Per Share, Diluted | $0.94 | $0.82 | $0.72 | $0.58 | $1.57 | $1.98 | $2.16 | $0.84 | ($0.09) | ($6.74) | |
| Weighted Average Number of Shares Outstanding, Basic | 74.4m | 76.9m | 82.9m | 85.6m | 84.7m | 84.7m | 83.0m | 80.1m | 77.0m | 76.7m | |
| Weighted Average Number of Shares Outstanding, Diluted | 79.2m | 79.1m | 84.0m | 86.5m | 85.2m | 85.5m | 83.5m | 80.3m | 77.0m | 76.7m | |
| Research and Development Expense | $58.2m | $63.5m | $78.0m | — | — | — | — | — | — | — | |
| Selling, General and Administrative Expense | $455.6m | $624.1m | $690.7m | $687.6m | $594.5m | $637.4m | $616.3m | $656.6m | $717.0m | $699.7m | |
| Other Nonoperating Income (Expense) | $845k | $1.3m | $8.3m | $9.5m | $4.4m | $19.3m | $12.0m | $3.7m | $3.9m | ($2.4m) | |
| Interest Expense (non-operating) | — | — | — | — | — | — | — | — | $70.6m | $86.3m | |
| Costs and Expenses | $876.7m | $1.1b | $1.4b | $1.4b | $1.2b | $1.3b | $1.3b | $1.4b | $1.6b | $2.1b | |
| Current Income Tax Expense (Benefit) | $22.3m | $13.9m | $4.8m | $28.9m | $23.8m | $48.4m | $37.9m | $25.2m | $9.4m | $19.2m | |
| Interest Expense | $25.8m | $35.0m | $64.7m | $54.0m | $71.6m | $50.4m | $49.6m | $51.4m | — | — | |
| Operating Lease, Expense | — | — | — | $19.6m | $19.7m | $20.3m | $22.6m | $24.0m | $24.3m | $23.9m | |
| Share-based Payment Arrangement, Expensed and Capitalized, Amount | $500k | — | — | — | — | — | — | — | — | — | |
| Income Tax Expense (Benefit) | $15.8m | ($53.4m) | ($3.4m) | $9.9m | ($40.4m) | $45.6m | $33.3m | $13.3m | ($11.3m) | ($47.0m) | |
| Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement | — | — | — | ($602k) | $102k | ($51k) | $0 | $0 | $144k | $13k |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.